Bone metastasis tumor diagnosis and treatment integrated carbon-based nano platform as well as preparation method and application thereof
By developing a multimodal imaging capability integrated carbon-based nano-platform platform for bone metastasis diagnosis and treatment, using watermelon derivatives to synthesize boron/nitrogen/manganese co-doped carbon dots and outer coated with hyaluronic acid and alendronate sodium, the radiation, nonspecific and high cost problems in the early diagnosis and treatment of bone metastasis tumors are solved, and efficient and precise treatment of bone metastasis tumors is achieved.
Patent Information
- Application Number
- CN202411870788.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-12-18
- Publication Date
- 2025-03-28
AI Technical Summary
The prior art has problems of radiation, nonspecificity and high cost in the early accurate diagnosis and treatment of bone metastases, and conventional chemotherapy is difficult to effectively inhibit the growth of bone metastases.
A carbon-based nano-platform platform for diagnosis and treatment of bone metastases with multimodal imaging capabilities was developed. Through watermelon derivatives as carbon sources, boron/nitrogen/manganese co-doped carbon dots were synthesized by a one-pot hydrothermal method, and hyaluronic acid and alendronate sodium were coated to achieve NIR-IIFL/PA/AMRI imaging, phototherapy and chemokinetic therapy.
This nanoplatform has the ability to actively and passively target bone metastases, and can perform synergistic anti-tumor and bone repair, achieve effective inhibition of bone metastases, and improve the accuracy and safety of treatment.